{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:26:28Z","timestamp":1790576788551,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.radonc.2024.110260","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T03:47:28Z","timestamp":1711511248000},"page":"110260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Assessment of minimum target dose as a predictor of local failure after spine SBRT"],"prefix":"10.1016","volume":"195","author":[{"given":"Roman O.","family":"Kowalchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trey C.","family":"Mullikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant M.","family":"Spears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Johnson-Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L.","family":"Siontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Kun Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9522-014X","authenticated-orcid":false,"given":"Satomi","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Lucido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Stish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Waddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia N.","family":"Laack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Merrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110260_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00196-0","article-title":"Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2\/3 trial","author":"Sahgal","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0010","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prro.2013.05.001","article-title":"RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1\u20133) spine metastases: phase 2 results","volume":"4","author":"Ryu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0015","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110260_b0020","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for Oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.prro.2021.12.012","article-title":"Cost-effectiveness of treatment strategies for spinal metastases","volume":"12","author":"Kowalchuk","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0030","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.prro.2022.01.011","article-title":"Development and internal validation of a recursive partitioning analysis-based model predictive of pain flare incidence after spine stereotactic body radiation therapy","volume":"12","author":"Kowalchuk","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0035","article-title":"Single and multifraction spine stereotactic body radiation therapy and the risk of radiation induced myelopathy","volume":"7","author":"Lucido","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3171\/2022.2.SPINE211613","article-title":"Independent predictors of vertebral compression fracture following radiation for metastatic spine disease","volume":"37","author":"Mikula","year":"2022","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2024.110260_b0045","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1016\/j.prro.2022.06.005","article-title":"In reply to cassidy and Amdur","volume":"12","author":"Kowalchuk","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0050","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2013.50.1411","article-title":"Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score","volume":"31","author":"Sahgal","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0055","article-title":"Spinal cord dose tolerance to stereotactic body radiation therapy","author":"Sahgal","year":"2019","journal-title":"Int J Radiat Oncol* Biology* Physics"},{"key":"10.1016\/j.radonc.2024.110260_b0060","article-title":"Development and validation of a recursive partitioning analysis\u2013based pretreatment decision-making tool identifying ideal candidates for spine stereotactic body radiation therapy","author":"Kowalchuk","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110260_b0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3171\/2020.6.SPINE20861","article-title":"Stereotactic body radiation therapy for spinal metastases: a novel local control stratification by spinal region","volume":"34","author":"Kowalchuk","year":"2021","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2024.110260_b0070","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11060-020-03534-4","article-title":"Stereotactic radiosurgery for the treatment of bulky spine metastases","volume":"148","author":"Kowalchuk","year":"2020","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2018.06.047","article-title":"Imaging-based outcomes for 24 gy in 2 daily Fractions for patients with de novo spinal metastases treated with spine stereotactic body radiation therapy (SBRT)","volume":"102","author":"Tseng","year":"2018","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-020-03691-6","article-title":"Local control and patterns of failure for \u201cradioresistant\u201d spinal metastases following stereotactic body radiotherapy compared to a \u201cradiosensitive\u201d reference","volume":"152","author":"Zeng","year":"2021","journal-title":"J Neuro-Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijrobp.2022.05.043","article-title":"Mature local control and reirradiation rates Comparing spine stereotactic body radiation therapy with conventional palliative external beam radiation therapy","volume":"114","author":"Zeng","year":"2022","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0090","doi-asserted-by":"crossref","first-page":"e597","DOI":"10.1016\/j.ijrobp.2012.03.009","article-title":"International spine radiosurgery consortium consensus guidelines for Target volume definition in spinal stereotactic radiosurgery","volume":"83","author":"Cox","year":"2012","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2019.11.026","article-title":"International consensus recommendations for target volume delineation specific to sacral metastases and spinal stereotactic body radiation therapy (SBRT)","volume":"145","author":"Dunne","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.radonc.2022.05.035","article-title":"Deviation from consensus contouring guidelines predicts inferior local control after spine stereotactic body radiotherapy","volume":"173","author":"Chen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0105","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1\u2014Update and clarification: from the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Can"},{"key":"10.1016\/j.radonc.2024.110260_b0110","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaoncol.2019.0192","article-title":"Single-Fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases","volume":"5","author":"Nguyen","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0115","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM task group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0120","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ijrobp.2015.03.037","article-title":"Outcomes for spine stereotactic body radiation therapy and an analysis of predictors of local recurrence","volume":"1","author":"Bishop","year":"2015","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0125","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2015.03.029","article-title":"Salvage stereotactic body radiotherapy (SBRT) following in-field failure of initial SBRT for spinal metastases","volume":"1","author":"Thibault","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0130","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/BRS.0b013e3181b8b6f5","article-title":"Radiotherapy and radiosurgery for metastatic spine disease: what are the options, indications, and outcomes?","author":"Gerszten","year":"2009","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.radonc.2024.110260_b0135","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0360-3016(98)00288-0","article-title":"Clinical results of nonsurgical treatment for spinal metastases","volume":"42","author":"Katagiri","year":"1998","journal-title":"Int J Radiat Oncol* Biol* Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0140","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijrobp.2020.09.019","article-title":"24\/TROG 17.06: a randomized phase II\/III study Comparing 24Gy in 2 stereotactic body radiotherapy (SBRT) Fractions versus 20Gy in 5 conventional palliative radiotherapy (CRT) Fractions for patients with painful spinal metastases","volume":"108","author":"Sahgal","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0145","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2021.01.004","article-title":"Phase 3 multi-center, prospective, randomized trial comparing single-dose 24 Gy radiation therapy to a 3-Fraction SBRT regimen in the treatment of Oligometastatic cancer","volume":"110","author":"Zelefsky","year":"2021","journal-title":"Int J Radiat Oncol*Biol*Phys"},{"key":"10.1016\/j.radonc.2024.110260_b0150","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamaoncol.2021.7008","article-title":"Development and assessment of a predictive score for vertebral compression fracture after stereotactic body radiation therapy for spinal metastases","volume":"8","author":"Kowalchuk","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110260_b0155","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1080\/0284186X.2018.1468089","article-title":"The use of a simultaneous integrated boost in spinal stereotactic body radiotherapy to reduce the risk of vertebral compression fractures: a treatment planning study","volume":"57","author":"van der Velden","year":"2018","journal-title":"Acta Oncologica"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024001828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T17:39:23Z","timestamp":1741455563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024001828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":31,"alternative-id":["S0167814024001828"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110260","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of minimum target dose as a predictor of local failure after spine SBRT","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110260"}}